NIAGEN BIOSCIENCE, INC. Non Peo Neo Avg Total Comp Amt
NIAGEN BIOSCIENCE, INC. (NAGE) reported Non Peo Neo Avg Total Comp Amt of $637.24 thousand for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-29.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-04-29
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $637.24K DEF 14A · filed 2026-04-29 |
| 2024-12-31 | $408.68K DEF 14A · filed 2026-04-29 |
| 2023-12-31 | $691.59K DEF 14A · filed 2026-04-29 |
| 2022-12-31 | $721.42K DEF 14A · filed 2026-04-29 |
| 2021-12-31 | $786.26K DEF 14A · filed 2026-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |